Literature DB >> 11145482

Cholinesterase inhibitors: expanding applications.

J L Cummings1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 11145482     DOI： 10.1016/S0140-6736(00)03393-6

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  7 in total

Review 1.  Hemispatial neglect.

Authors:  A Parton; P Malhotra; M Husain
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-01       Impact factor: 10.154

2.  Combined actions of blueberry extract and lithium on neurochemical changes observed in an experimental model of mania: exploiting possible synergistic effects.

Authors:  Luiza Spohr; Mayara Sandrielly Pereira Soares; Pathise Souto Oliveira; Bruna da Silveira de Mattos; Natália Pontes Bona; Nathalia Stark Pedra; Fernanda Cardoso Teixeira; Carlus Augustu Tavares do Couto; Vitor Clasen Chaves; Flávio Henrique Reginatto; Meibel Teixeira Lisboa; Anderson Schwingel Ribeiro; Claiton Leoneti Lencina; Francieli Moro Stefanello; Roselia Maria Spanevello
Journal:  Metab Brain Dis       Date:  2018-12-07       Impact factor: 3.584

Review 3.  Dementia with Lewy bodies. Review of diagnosis and pharmacologic management.

Authors:  Christopher Frank
Journal:  Can Fam Physician       Date:  2003-10       Impact factor: 3.275

4.  Olfactory Hallucinations without Clinical Motor Activity: A Comparison of Unirhinal with Birhinal Phantosmia.

Authors:  Robert I Henkin; Samuel J Potolicchio; Lucien M Levy
Journal:  Brain Sci       Date:  2013-11-15

5.  The evaluation of cognitive function in the dementias: methodological and regulatory considerations.

Authors:  Keith A Wesnes; John E Harrison
Journal:  Dialogues Clin Neurosci       Date:  2003-03       Impact factor: 5.986

6.  New 2-Aryl-9-methyl-β-carbolinium salts as Potential Acetylcholinesterase Inhibitor agents: Synthesis, Bioactivity and Structure-Activity Relationship.

Authors:  Bohang Zhou; Bingyu Zhang; Xingqiang Li; Xiuxiu Liu; Hui Li; Ding Li; Zhiming Cui; Huiling Geng; Le Zhou
Journal:  Sci Rep       Date:  2018-01-24       Impact factor: 4.379

7.  Rivastigmine in the treatment of patients with Alzheimer's disease.

Authors:  Thomas Müller
Journal:  Neuropsychiatr Dis Treat       Date:  2007-04       Impact factor: 2.570
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.